CD44 SNP rs187115: A novel biomarker signature that predicts survival in resectable pancreatic ductal adenocarcinoma.
<h4>Purpose</h4> <p>Although pancreatic ductal adenocarcinoma (PDAC) is an aggressive tumor, like other common cancers, it displays a wide range of biology. However, at present, there are no reliable tests to predict patients’ cancer-specific outcomes and guide personalized treatme...
Hlavní autoři: | Stracquadanio, G, Vrugt, B, Flury, R, Schraml, P, Würl, P, Müller, T, Knippschild, U, Henne-Bruns, D, Breitenstein, S, Clavien, P, Graf, R, Bond, G, Grochola, L |
---|---|
Médium: | Journal article |
Jazyk: | English |
Vydáno: |
American Association for Cancer Research
2016
|
Podobné jednotky
-
Prognostic Relevance of hTERT mRNA Expression in Ductal Adenocarcinoma of the Pancreas
Autor: Lukasz-Filip Grochola, a další
Vydáno: (2008-09-01) -
MDM2 SNP309 associates with accelerated pancreatic adenocarcinoma formation.
Autor: Grochola, L, a další
Vydáno: (2010) -
Chemosensitivity profiles identify polymorphisms in the p53 network genes 14-3-3tau and CD44 that affect sarcoma incidence and survival.
Autor: Vazquez, A, a další
Vydáno: (2010) -
Lack of association of CD44-rs353630 and CHI3L2-rs684559 with pancreatic ductal adenocarcinoma survival
Autor: Manuel Gentiluomo, a další
Vydáno: (2021-04-01) -
Cough induced rib fracture, rupture of the diaphragm and abdominal herniation
Autor: Wurl Peter, a další
Vydáno: (2006-11-01)